Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Aug 07, 2026
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.(Image credit: Fred Tanneau)
https://www.npr.org/2026/08/07/nx-s1-5922530/patients-betting-kalshi-polymarket-clinical-trials
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service